- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07942818
Clinical Outcomes of the Modified Direct Lateral Approach Versus the Modified Anterolateral Approach in Hip Arthroplasty Performed in the Lateral Decubitus Position
Clinical Outcomes of the Modified Direct Lateral Approach Versus the Modified Anterolateral Approach in Hip Arthroplasty Performed in the Lateral Decubitus Position: A Prospective Randomized Controlled Trial
The purpose of this clinical trial is to compare two surgical approaches used during primary hip replacement surgery (hip arthroplasty): the modified direct lateral approach and the modified anterolateral approach. Both surgical approaches are performed while the patient is lying on their side (the lateral decubitus position).
Hip replacement surgery is an established treatment for severe hip joint conditions such as end-stage hip osteoarthritis, helping to reduce pain and improve physical function and quality of life. Different surgical pathways to reach the hip joint interact differently with the surrounding hip abductor muscles, which may affect early recovery, walking ability, and daily physical function.
In this study, 300 adult participants (aged 18 years and older) scheduled for primary total hip replacement or partial hip replacement (hemiarthroplasty) at Assiut University Hospital will be randomly assigned, like flipping a coin, to one of two equal groups:
- Modified Direct Lateral Approach Group: Participants will undergo hip replacement using the modified Hardinge approach, which reaches the hip joint from the side and involves partially splitting and elevating the front portion of the hip abductor muscle tendon.
- Modified Anterolateral Approach Group: Participants will undergo hip replacement using the modified Watson-Jones approach, which reaches the hip joint through a natural space between two muscles at the front-side of the hip without splitting the abductor muscle.
Before surgery and at follow-up visits 6 weeks, 3 months, 6 months, and 12 months after surgery, participants will complete the Hip Disability and Osteoarthritis Outcome Score (HOOS) questionnaire to evaluate their ability to perform activities of daily living. Researchers will also examine hip X-rays to check implant positioning and monitor participants for any surgical complications for up to 1 year after surgery.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Aged 18 years or older
- Indicated for primary hip arthroplasty
- Ambulatory before surgery, with or without a walking aid
- Able to understand the study and complete the Hip Disability and Osteoarthritis Outcome Score (HOOS) questionnaire
- Willing to participate and sign written informed consent
- Able and willing to comply with standardized postoperative rehabilitation
Exclusion Criteria:
- Previous hip surgery (e.g., first-stage procedure)
- Developmental hip dysplasia
- Severe proximal femoral deformity or severe acetabular bone deficiency
- Ankylosed or severely stiff hip
- Neurological disorders significantly affecting gait or hip function
- Cognitive impairment preventing reliable assessment
- Uncontrolled medical conditions
- Body mass index (BMI) greater than 40
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Modified Direct Lateral Approach
Patients undergoing primary hip arthroplasty (total hip arthroplasty or hemiarthroplasty) via the modified direct lateral (Hardinge) surgical approach performed in the lateral decubitus position. |
Primary total hip arthroplasty or hemiarthroplasty performed using the modified direct lateral (Hardinge) surgical approach in the lateral decubitus position. This technique provides direct joint access through the lateral aspect and involves partial splitting and elevation of the anterior portion of the gluteus medius and minimus tendons. |
|
Active Comparator: Modified Anterolateral Approach
Patients undergoing primary hip arthroplasty (total hip arthroplasty or hemiarthroplasty) via the modified anterolateral (Watson-Jones) intermuscular surgical approach performed in the lateral decubitus position. |
Primary total hip arthroplasty or hemiarthroplasty performed using the modified anterolateral (Watson-Jones) surgical approach in the lateral decubitus position. This intermuscular technique enters through the interval between the tensor fasciae latae and gluteus medius to preserve abductor tendon continuity. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change From Baseline in Hip Disability and Osteoarthritis Outcome Score (HOOS) Activities of Daily Living (ADL) Subscale Score
Time Frame: Baseline (preoperative) and 12 months postoperatively
|
The Hip Disability and Osteoarthritis Outcome Score (HOOS 2.0) Activities of Daily Living (ADL) subscale is a validated patient-reported outcome measure assessing functional ability during daily activities. Raw scores are transformed to a 0 to 100 scale, where 0 indicates extreme hip problems and 100 indicates no hip problems. A positive change from baseline represents functional improvement. |
Baseline (preoperative) and 12 months postoperatively
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Hip Arthroplasty Approaches
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.